ENDPOINTS

SV Health Investors nabs $250M to fund dementia-focused biotechs

SV Health Investors has added $250 million to its hunt for new therapeutics for dementia, Alzheimer's and other neurodegenerative diseases. The London-based life sciences investor said Thursday it secured that amount ...

Mar 20, 2025 - 18:17
 0
SV Health Investors nabs $250M to fund dementia-focused biotechs
SV Health Investors has added $250 million to its hunt for new therapeutics for dementia, Alzheimer's and other neurodegenerative diseases. The London-based life sciences investor said Thursday it secured that amount ...
Read More

Tags:

Previous Article

Evangelina Rodríguez Traveled to Paris to Revolutionize Health Care in the Domin...

Next Article

The Earth Observer Editor’s Corner: January–March 2025

Related Posts

FDA blocks drug and device reviewers from taking HHS' buyout offer

FDA blocks drug and device reviewers from taking HHS' b...

Mar 10, 2025  0

Misleading promotion lands NJ drugmaker a letter from FDA

Misleading promotion lands NJ drugmaker a letter from FDA

Mar 4, 2025  0

Walgreens turns on dark mode

Walgreens turns on dark mode

Mar 11, 2025  0